Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Neuspera Neurostimulation System (NNS)

K-Number: K202781 · 2021-08-27

Decision Date2021-08-27
Product CodeGZF
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

Neuspera Neurostimulation System (NNS) is the device name listed in this FDA 510(k) record. The listed applicant is Neuspera Medical, Inc.. It received FDA 510(k) clearance on 2021-08-27 under 510(k) number K202781. The device is classified under product code GZF. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Neuspera Neurostimulation System (NNS)?

Neuspera Neurostimulation System (NNS) is a medical device that received FDA 510(k) clearance on 2021-08-27. The listed applicant is Neuspera Medical, Inc.. The 510(k) number is K202781.

When did Neuspera Neurostimulation System (NNS) receive FDA 510(k) clearance?

Neuspera Neurostimulation System (NNS) received FDA 510(k) clearance on 2021-08-27, under 510(k) number K202781.

Who is the listed applicant for Neuspera Neurostimulation System (NNS)?

The FDA 510(k) record lists Neuspera Medical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Neuspera Neurostimulation System (NNS)?

The FDA product code for Neuspera Neurostimulation System (NNS) is GZF.

Other records listing Neuspera Medical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: GZF)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.